Phytopharm Share Discussion Threads

[whereareallthemugpuntersyachts] 18/2/2013 07:14

Commenting on these results, Tim Sharpington, CEO said: "We are naturally disappointed with the outcome of this study of Cogane(TM) in patients with Parkinson's disease. Cogane(TM) had demonstrated encouraging efficacy in a wide range of industry standard pre-clinical models but this promise has not translated into clinically meaningful efficacy in this study."

[whereareallthemugpuntersyachts] 18/2/2013 07:12

TOP Traders Thread !!!! - CR
TOPINFO - 14 Feb 2013 - 14:53:59 - 214696 of 215709
PYM 10.39p paid against offer 10.25p. Not many in yet on here. News any day now.

TOP Traders Thread !!!! - CR
TOPINFO - 14 Feb 2013 - 14:53:10 - 214694 of 215709
Paying well over now PYM. I did tell yas at 8.6p.

I think good news is leaking!

TOP Traders Thread !!!! - CR
TOPINFO - 14 Feb 2013 - 14:50:07 - 214690 of 215709
PYM paying 10.25p now. :)))))))


TOP Traders Thread !!!! - CR
TOPINFO - 14 Feb 2013 - 14:22:37 - 214657 of 215709
PYM going over 10p !

[mrsapeslaptop] 17/2/2013 23:09

look. just stfu please.

NOT FULLY INVESTED YET.

the longer this goes on. th elonger they are looking for a positive from the results. a good drift down is needed.

if the results are great they would be out by now.

[crosswire] 17/2/2013 21:26

They are awaiting the results!They are prepared to fill out the page!It's blank at present.

[haroldthegreat] 17/2/2013 19:37

is that report genuine ? what checks does the website do to confirm the patient was on the trial ? if its a double blind trial it could be a placebo being used on that patient and they thought it was working!

[crosswire] 17/2/2013 12:27

Awaiting results:

Parkinson's Phase 2 Study Cogane (PYM50028) CONFIDENT-PD Treatment Report

[galacticus] 16/2/2013 11:13

ell it would seem the powers that be keep on holding back trades , i saw a magnitude of buys go threw at 9.98 yesterday and a big delayed after hour trade from Thursday bang on mid , from experience id speculate if we had a big seller they woukld shoot up 10% get loads of buyers buying and hold it and show buys as blue to help fill , in this instance it seems quite the opposite as you could sell good volume at 9.9 all day Friday and lots of buys at 9.98 showing red adding to my theory that they are trying to tease out sells to fill orders , if so very encouraging with news due , the old hats here will know on aim bad news 3-4 big % days not really based on volume , if good hold it bk keep interest away till post rns and flash up buys a day or two later manipulating the spread to scare the less savvy , the deal isnt done but its been 3 years in the waiting and if half as good as primates could make global news imo and very healthy profits for holders.

[jondev] 15/2/2013 09:40

Agreed, give it a rest crossfire

[ewads] 15/2/2013 09:04

MrsApeslaptop 15 Feb'13 - 00:17 - 391 of 395

Good reality check - All the 'crosswire' ramping does not do much , as we've seen it all before.

It will be a great achievement if they get a result; which I guess is why most are invested here. To say it's all a done deal is nonsence.

[crosswire] 15/2/2013 08:35

All buys: 9.98p are all buys!!

mm games!

[galacticus] 15/2/2013 07:29

mrs A , last RNS states coverd till end of Q1 2014 at least , if you look at AGL of late after ground breaker went from 30p to 90p spike out then raise at 50p we are in a much better financial state , also big pharmies hinted at in last statement waiting in the wings on these results ,plus that Edison is a long time ago when ALS was at very early stage with Phase 1 in Q1 results this is a big added extra as at present worh $200 million a year but stated any decent solution ie maybe ours would be worth 2 billion a year with an end to end medication, VERY REAL CHANCE OF JV OR T/O here soon on good results.

[crosswire] 15/2/2013 07:08

"We have also had discussions with the FDA and potential pharmaceutical partners about how best to complete the development and commercialisation of Cogane™."

"The results from the CONFIDENT-PD clinical trial will be important in determining how our future strategy evolves and we look forward to receiving these results shortly".


----------------------------------------------------------------------

Shortly, as in by 28th February, and they are ready to commercialise Cogane!!

[mrsapeslaptop] 15/2/2013 00:17

although heavily invested for several years.

a) Edison research note troubles me
- it is often a sign of a looming placing
- if P2 successful, 25p seems very low estimate

so combined troubles me.

as always DYOR, but its a thinly traded stock so more volatile than most, and dont get sucked into a ramp up to results.

[galacticus] 14/2/2013 19:55

well results aside , graph looks set for big break out MACD mega positive and break of bolingers , only a few trading days to wait and if all good Q1 ALS results , big pharmas etc, allot rests on this rns , if half as good as primates will make global news .

[crosswire] 14/2/2013 18:21

LSE:

intherealworld
Posts: 26
Off Topic
Opinion: Strong Buy
Price: 9.88

View Thread (2)RE: NRToday 16:26

Edison Research (employed by Phytopharm) have a target price of 22 to 24p if the trial succeeds and a partner found.

Looking at potential earnings per share of 5 to 10p, with a p/e ratio of 5 to 8 (average bio co) I estimate a far higher price could be on the cards.

There could also be a potential takeover if a major pharma wants to buy market share in a innovative drug offering

I was on the trial, and hold over 2 million shares so have my fingers crossed for success.

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

Blimey, this guy was on the trial and holds 2 million shares!

Now that inspires confidence!

He/she must have seen a vast improvement to buy 2 million PYM!

Roll on trial results!

[crosswire] 14/2/2013 18:13

Let's hope we get good results and catch the mm's with "their pants down"!

Absolute *ankers for keeping share price static considering the number of buys!!

Blatant manipulation!

Rant over!

[piccolino3] 14/2/2013 15:50

More likely the MM's are taking shares back from H to meet current demand and keep the price from running away.

[jondev] 14/2/2013 14:21

they went down from 11% to 10.9% and are acting on behalf of a group holding. Just a minor fluctuation. If it was a bailout it would have been more noticeable.

[bla1se] 14/2/2013 12:41

Why? Do you think they're bailing?

[mrsapeslaptop] 14/2/2013 11:34

yes. I think the next threshold is 8% though.

[jondev] 14/2/2013 11:22

Only by a tiny smidge

[mrsapeslaptop] 14/2/2013 10:53

RNS looks like Henderson global investors have reduced their stake

[crosswire] 14/2/2013 06:46

Back in 2009:

Phytopharm's share price went stratospheric, climbing a massive 324 per cent after the Cambridge company announced that Cogane, its target for Parkinson's disease, had shown hugely promising data in two early studies.

Phytopharm said the positive results justify Phytopharm's stated strategy to move forward rapidly to a Phase II, proof-of-concept study for Cogane in patients with PD, which is planned to commence in Q2, 2010.

After 3 years: The results are due:


The last patient completed participation in the CONFIDENT-PD Phase II clinical trial of Cogane™ in untreated patients with early-stage Parkinson's disease in December 2012. Results from this trial remain on track to be available in February 2013.